Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-197032
Filing Date
2024-08-08
Accepted
2024-08-08 16:46:24
Documents
5
Effectiveness Date
2024-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 d845604ds8.htm S-8 60118
2 EX-5.1 d845604dex51.htm EX-5.1 8965
3 EX-23.1 d845604dex231.htm EX-23.1 1454
4 EX-FILING FEES d845604dexfilingfees.htm EX-FILING FEES 49308
5 GRAPHIC g845604g0806072917225.jpg GRAPHIC 2196
  Complete submission text file 0001193125-24-197032.txt   124310
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281393 | Film No.: 241189225
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)